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cancer (25%), neurological dysfunction (11, 1%), peripheral arte-
riopathy (66.7%), previous cardiac surgery (41, 6%), diabetes (27,
7%), severe pulmonary hypertension higher than 60 mmHg (16,
7%), moderate LV EF more than 50% (50, 05%), and LVEF less
than 30% (19, 4%). Certain variables do not ﬁgure in the algo-
rithm as porcelain aorta (36, 1%) and mediastinal irradiation (5,
5%). Observed in-hospital death was 18.2%. The actual and pre-
dicted mortality were compared.
Results: Operative mortality (30 days) = 5 patients (15.6%). An
additional 5 patients (15.6%) died during the follow-up study period
of 587days (mean 324 ± 164). Overall mortality = 10 patients
(31.2%). Both the STS and EuroSCORE failed to demonstrate sig-
niﬁcant correlation with predicted operative mortality (HR= 0.97,
[95% CI 0.98–1.06] p= 0.536 and HR= 0.99, [95% CI 0.90–1.08]
p= 0.818, respectively). The STS algorithm seemsmore accurate in
estimating the operative mortality in TAVI patients.
Conclusion: Current surgical scores correlate poorly with the
observed outcome. Reﬁning these scores for high risk patients
requiring aortic valve surgery may improve patient selection for
TAVI.
Tracks: Cardiovascular Surgery.
doi:10.1016/j.jsha.2010.02.343
SHA 68. Transapical aortic valve implantation
Dr. Feras H. Khaliel a, Dr. Nawwar Al-attar b
a Fellow Cardiovascular Surgeon, ICM
b Consultant Cardiovascular Surgeon, Bichat Hospital
Objectives: Aortic valve replacement (AVR) is indicated in se-
vere symptomatic AS, but limitation can be present in doing the
golden standard. Hereby, the presence of another minimal inva-
sive technique (TVAI) will bypasses these limitations in high risk
patients.
Methods: The total experience with TAVI is well over 600 pa-
tients. In our centre, 50 patients were consecutively treated with
TAVI with a mean age of 83 ± 6 years, and a predicted surgical
mortality of 28 ± 14% and 16 ± 7% using the EuroSCORE and
STS score, respectively. Thirty-ﬁve patients were treated via the
TF and 15 via the TA approach using the Edwards SAPIEN valve.
Results: The implantation success rate of the transapical proce-
dure was 93%, survival after 6 months is around 70%. TA pa-
tients had a 30 day mortality of 10.3%. The stroke rate was
2.4% and pacemaker implantation rate was 6.7%. Vascular com-
plication rate <3%. In our centre comordities were more frequent
in TA patients. Successful implantation was 85.7% and 100% in
the TF and TA group, respectively. Stroke in the TF group was
(6%) and non in the TA, while mortality rate was 8% and 27%,
respectively.
Conclusion: Although early results of TAVI are encouraging,
this procedure has a potential for serious complications. Careful
selection of high risk patients are demanded for better results with
lower complication rate.
Tracks: Adult Cardiology.
doi:10.1016/j.jsha.2010.02.344
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Objectives: Evaluate and improve the timeliness of service given
to patients in nurse directed outpatient cardiac disease manage-
ment clinics. As cardiac centers provide acute care that prolongs
life, there is an increasing responsibility to provide quality cardiac
outpatient care. An increasing number of centers are providing
tertiary care; however, there has not been a corresponding increase
in the availability and quality of outpatient care. We are in the
process of evaluating this gap in care at our institution. This study
focuses on waiting time and time spent with the clinical nurse spe-
cialist in our Congestive Heart Failure (CHF) and Atherosclerosis
disease management clinics.
Methods: This study is based on data on visits for the month of
October 2009.
Results: We were pleased to ﬁnd acceptable waiting times for
both the CHF and Atherosclerosis Clinics 24 (range 10–32) and
24 (range 13–30) min, respectively. Work will continue in an effort
to improve on this performance. What was somewhat unexpected,
however, was the longer average time spent with Atherosclerosis
patients as compared to CHF patients 41 (range 38–45) vs. 38
(range 31–44) min. It is important to note that the time slot for
each visit is 30 min. An average time of 60 (range 22–80) min,
was spent with new patients admitted to the Atherosclerosis and
CHF clinics. Remarkably service to walk-in patients was better
than expected. Average waiting time was 32 min (range 23–
58 min). Time spent with nurses averaged 29.5 min (range 22–
45 min). Currently patients attending the clinic for medication re-
ﬁlls are not tracked; however, this workload will be monitored and
evaluated in the future.
Conclusion: In summary this study suggests that the allocated
time for patient visits for the Atherosclerosis and CHF clinics
may need to be increased to better accommodate the needs of pa-
tients. This information is important for those centers planning
disease management facilities in the region as it will help them
in evaluating the number of clinics and staff they will need.
Tracks: Adult Cardiology.
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Introduction: Truncus arteriosus (TA) is an uncommon congen-
ital cardiac malformation, accounting for approximately 1.2% of
all congenital heart malformations. Repair of TA is associated
with a signiﬁcant morbidity and mortality. Reintervention after
TA repair is a concern in the mid and long-term follow-up.
Objectives: The aim of the study is to evaluate our experience
with TA repair looking for short and midterm outcome and the
need for reintervention.
Methodology: Databases and chart review analysis of all patients
who underwent TA repair at our centre during the period from
December 2001 till October 2008 was conducted. Truncal valve
morphology with or without truncal valve stenosis and/or insufﬁ-
ciency were recorded (pre and post-surgery). The requirement for
reintervention, morbidity, and mortality were also reviewed.
Results: From a total of 25 patients with TA, 21 fulﬁll the
inclusion criteria. Eleven (52%) of them were females. Sixteen
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